148 related articles for article (PubMed ID: 26183184)
1. Induced tigecycline resistance in Streptococcus pneumoniae mutants reveals mutations in ribosomal proteins and rRNA.
Lupien A; Gingras H; Leprohon P; Ouellette M
J Antimicrob Chemother; 2015 Nov; 70(11):2973-80. PubMed ID: 26183184
[TBL] [Abstract][Full Text] [Related]
2. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms and fitness costs of tigecycline resistance in Escherichia coli.
Linkevicius M; Sandegren L; Andersson DI
J Antimicrob Chemother; 2013 Dec; 68(12):2809-19. PubMed ID: 23843301
[TBL] [Abstract][Full Text] [Related]
4. Genomics of KPC-producing Klebsiella pneumoniae sequence type 512 clone highlights the role of RamR and ribosomal S10 protein mutations in conferring tigecycline resistance.
Villa L; Feudi C; Fortini D; García-Fernández A; Carattoli A
Antimicrob Agents Chemother; 2014; 58(3):1707-12. PubMed ID: 24379204
[TBL] [Abstract][Full Text] [Related]
5. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR.
Wang X; Chen H; Zhang Y; Wang Q; Zhao C; Li H; He W; Zhang F; Wang Z; Li S; Wang H
Int J Antimicrob Agents; 2015 Jun; 45(6):635-40. PubMed ID: 25681067
[TBL] [Abstract][Full Text] [Related]
6. Multiple mutations and increased RNA expression in tetracycline-resistant Streptococcus pneumoniae as determined by genome-wide DNA and mRNA sequencing.
Lupien A; Gingras H; Bergeron MG; Leprohon P; Ouellette M
J Antimicrob Chemother; 2015 Jul; 70(7):1946-59. PubMed ID: 25862682
[TBL] [Abstract][Full Text] [Related]
7. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline.
McAleese F; Petersen P; Ruzin A; Dunman PM; Murphy E; Projan SJ; Bradford PA
Antimicrob Agents Chemother; 2005 May; 49(5):1865-71. PubMed ID: 15855508
[TBL] [Abstract][Full Text] [Related]
8. In vivo development of tigecycline resistance in Klebsiella pneumoniae owing to deletion of the ramR ribosomal binding site.
Ye M; Ding B; Qian H; Xu Q; Jiang J; Huang J; Ou H; Hu F; Wang M
Int J Antimicrob Agents; 2017 Oct; 50(4):523-528. PubMed ID: 28668690
[TBL] [Abstract][Full Text] [Related]
9. Preclinical pharmacology of GAR-936, a novel glycylcycline antibacterial agent.
Projan SJ
Pharmacotherapy; 2000 Sep; 20(9 Pt 2):219S-223S; discussion 224S-228S. PubMed ID: 11001329
[TBL] [Abstract][Full Text] [Related]
10. Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007-10) and role of an efflux pump in tigecycline non-susceptibility.
Roy S; Datta S; Viswanathan R; Singh AK; Basu S
J Antimicrob Chemother; 2013 May; 68(5):1036-42. PubMed ID: 23335112
[TBL] [Abstract][Full Text] [Related]
11. Genomic analysis and reconstruction of cefotaxime resistance in Streptococcus pneumoniae.
Fani F; Brotherton MC; Leprohon P; Ouellette M
J Antimicrob Chemother; 2013 Aug; 68(8):1718-27. PubMed ID: 23608923
[TBL] [Abstract][Full Text] [Related]
12. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase.
Chen Q; Li X; Zhou H; Jiang Y; Chen Y; Hua X; Yu Y
J Antimicrob Chemother; 2014 Jan; 69(1):72-6. PubMed ID: 23928024
[TBL] [Abstract][Full Text] [Related]
13. The ribosomal S10 protein is a general target for decreased tigecycline susceptibility.
Beabout K; Hammerstrom TG; Perez AM; Magalhães BF; Prater AG; Clements TP; Arias CA; Saxer G; Shamoo Y
Antimicrob Agents Chemother; 2015 Sep; 59(9):5561-6. PubMed ID: 26124155
[TBL] [Abstract][Full Text] [Related]
14. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline.
Fluit AC; Florijn A; Verhoef J; Milatovic D
Antimicrob Agents Chemother; 2005 Apr; 49(4):1636-8. PubMed ID: 15793159
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Garrison MW; Nuemiller JJ
Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
[TBL] [Abstract][Full Text] [Related]
16. Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.
He F; Fu Y; Chen Q; Ruan Z; Hua X; Zhou H; Yu Y
PLoS One; 2015; 10(3):e0119064. PubMed ID: 25734903
[TBL] [Abstract][Full Text] [Related]
17. Step-Wise Increase in Tigecycline Resistance in Klebsiella pneumoniae Associated with Mutations in ramR, lon and rpsJ.
Fang L; Chen Q; Shi K; Li X; Shi Q; He F; Zhou J; Yu Y; Hua X
PLoS One; 2016; 11(10):e0165019. PubMed ID: 27764207
[TBL] [Abstract][Full Text] [Related]
18. Deletions in a ribosomal protein-coding gene are associated with tigecycline resistance in Enterococcus faecium.
Niebel M; Quick J; Prieto AM; Hill RL; Pike R; Huber D; David M; Hornsey M; Wareham D; Oppenheim B; Woodford N; van Schaik W; Loman N
Int J Antimicrob Agents; 2015 Nov; 46(5):572-5. PubMed ID: 26364847
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity of tigecycline against recent isolates of respiratory pathogens from Asian countries.
Ko KS; Song JH; Lee MY; Park S; Kwon KT; Heo ST; Ryu SY; Oh WS; Peck KR; Lee NY
Diagn Microbiol Infect Dis; 2006 Aug; 55(4):337-41. PubMed ID: 16631337
[TBL] [Abstract][Full Text] [Related]
20. Mutant prevention concentration of tigecycline for clinical isolates of Streptococcus pneumoniae and Staphylococcus aureus.
Hesje CK; Drlica K; Blondeau JM
J Antimicrob Chemother; 2015 Feb; 70(2):494-7. PubMed ID: 25324419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
